title: Disease modifying treatment in multiple sclerosis.
authors.affiliation: Department of Neurology, Gloucester Royal Hospital, UK. geraint@fullerg.demon.co.uk
authors.forename: G N
authors.initials: GN
authors.lastname: Fuller
authors.forename: I
authors.initials: I
authors.lastname: Bone
mesh_terms: D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
chemical_list: D007166:Immunosuppressive Agents; D010455:Peptides; D000068576:Interferon beta-1b; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D000068556:Interferon beta-1a